Despite cancelling some data center leases last quarter, Microsoft said it is currently seeing more demand for AI capacity ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...

TD Cowen analyst Daniel Brennan maintained a Buy rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target of ...

BTIG just kicked off coverage on Tempus AI (NASDAQ:TEM) with a Buy rating and a $60 price target suggesting nearly 48% upside from where the stock trades now. Analyst Mark Massaro called the ...

Investing.com -- TD Cowen downgraded Global Payments (NYSE:GPN) Inc. to Hold from Buy and slashed its price target to $78 from $110, warning that the company’s planned acquisition of Worldpay ...

Investing.com -- TD Cowen upgraded Fidelity National Information Services (NASDAQ:III) to “Buy” from “Hold” raising its price target to $92 from $80 driven by company’s shift toward a more stable and ...

Investing.com -- TD Cowen upgraded Fidelity National Information Services (NASDAQ:III) to “Buy” from “Hold” raising its price target to $92 from $80 driven by company’s shift toward a ...

Investing.com -- TD Cowen downgraded Global Payments (NYSE:GPN) Inc. to Hold from Buy and slashed its price target to $78 from $110, warning that the company’s planned acquisition of Worldpay ...

According to the TD Cowen analysis, Strategy’s bitcoin buys ... Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure ...

As previously reported, BTIG initiated coverage of Tempus AI (TEM) with a Buy rating and $60 price target Tempus AI is a rapidly growing precision medicine platform technology company, which has ...

Tempus AI grew revenue 30.4% YoY in FY2024 to $693.4M, with Q4 growth at 35.8%. Genomics drove 65% of FY2024 revenue at $451.7M with a suboptimal 49.2% gross margin and cost-intensive delivery.

Illumina Inc. and Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration to accelerate clinical adoption of ...